Government's Endorsement of Caldicott2 is a Landmark Milestone for Patient Privacy

FairWarning

FairWarning Inc., the inventor and global leader in patient privacy monitoring, has welcomed the UK government's response to the Caldicott Review, describing its decision to accept all of the recommendations in the review as "a significant step towards transparent care and a landmark milestone for both patients and the NHS."

But the company says the announcement, which coincides with the publication of the Health & Social Care Information Centre's (HSCIC) guide to confidentiality in health and social care, is just the latest step in the long journey towards electronic healthcare - and has urged healthcare stakeholders to work collaboratively to drive a culture of privacy throughout the NHS and ensure that the Caldicott2 recommendations are fully implemented within 12 months.

The Caldicott report was first published in April 2013, following an independent review into how information about individuals is shared across the health and social care system. FairWarningwas highly supportive of the original recommendations and is therefore extremely encouraged by the government’s decision to endorse all of the review's proposals.

FairWarning shares the government's view that effective information sharing will not only lead to better health outcomes, but it will also improve care pathways and enhance the patient experience. The company wholly supports the finding that there is no contradiction between increasing data sharing for care and improving the safeguards for personal confidential data.

However, electronic healthcare can only succeed if patients feel in greater control of their personal confidential information and are confident that the NHS is ensuring that information is secure, protected and shared appropriately. As such, moves to harness the power of information must be underpinned by robust information governance and information risk management processes that protect patient confidentiality.

Tim Dunn, General Manager for FairWarning UK commented: "Tools to help NHS professionals provide transparency on who is accessing patient records, and enabling trusts to monitor access proactively, are readily available and being successfully deployed in parts of the UK. We welcome that, in its response to Calidicott2, the government has acknowledged the implementation of privacy breach monitoring in Scotland. We believe that the full implementation of these recommendations could bring the rest of the UK to the high standard levels achieved in NHS Scotland, and ensure information assurance for UK trusts."

FairWarning considers the government's guidelines an important framework to ensure transparency and accountability for patient privacy. However, the company also believes the NHS' ability to implement the recommendations will be pivotal to the expansion of trust in digital healthcare.

Tim Dunn concluded: "It is now critical that Dame Fiona’s recommendations are implemented in a timely fashion, in line with the deadlines set out in the Caldicott Review and the response of the Department of Health (DH). Jeremy Hunt’s ambitions for electronic healthcare rely on executing this plan and protecting patient privacy will be at the heart of those efforts.

"The development of electronic healthcare models will indeed require both a step change and a concerted effort at national and local level. The time to act is now and FairWarning looks forward to supporting the DH and its partners in achieving these important goals."

About Caldicott2
The independent Information Governance Review led by Dame Fiona Caldicott, entitled 'Information: to share or not to share?' and also known as Caldicott2, was set up in February 2012 and delivered its final report and recommendations in April 2013. The aim of the review was to advise on how to achieve a better balance between protecting and sharing confidential personal information. The review produced a set of 7 revised "Caldicott Principles" and 26 specific recommendations. Dame Fiona will now chair an independent panel to oversee and scrutinise implementation of the review's recommendations and to provide advice on information governance issues.

About FairWarning, Inc.
FairWarning empowering care providers to grow their reputation for protecting confidentiality, scale their digital health initiatives and comply with complex privacy laws. By partnering with FairWarning, care providers are able to direct their focus on delivering the best patient outcomes possible while receiving expert, sustainable and affordable privacy and compliance solutions. Customers consider FairWarning such as ARRA HITECH privacy and meaningful use criteria, HIPAA, UK and EU Data Protection, and Canadian provincial healthcare privacy law.

Most Popular Now

AI may Help Clinicians Personalize Treat…

Individuals with generalized anxiety disorder (GAD), a condition characterized by daily excessive worry lasting at least six months, have a high relapse rate even after receiving treatment. Artificial intelligence (AI)...

Mobile App Tracking Blood Pressure Helps…

The AHOMKA platform, an innovative mobile app for patient-to-provider communication that developed through a collaboration between the School of Engineering and leading medical institutions in Ghana, has yielded positive results...

Can AI Help Detect Cognitive Impairment?

Mild cognitive impairment (MCI) can be an early indicator of Alzheimer's disease or dementia, so identifying those with cognitive issues early could lead to interventions and better outcomes. But diagnosing...

Accelerating NHS Digital Maturity: Paper…

Digitised clinical noting at South Tees Hospitals NHS Foundation Trust is creating efficiencies for busy doctors and nurses. The trust’s CCIO Dr Andrew Adair, deputy CCIO Dr John Greenaway, and...

Customized Smartphone App Shows Promise …

A growing body of research indicates that older adults in assisted living facilities can delay or even prevent cognitive decline through interventions that combine multiple activities, such as improving diet...

New Study Shows Promise for Gamified mHe…

A new study published in Multiple Sclerosis and Related Disorders highlights the potential of More Stamina, a gamified mobile health (mHealth) app designed to help people with Multiple Sclerosis (MS)...

Patients' Affinity for AI Messages …

In a Duke Health-led survey, patients who were shown messages written either by artificial intelligence (AI) or human clinicians indicated a preference for responses drafted by AI over a human...

New Research Explores How AI can Build T…

In today’s economy, many workers have transitioned from manual labor toward knowledge work, a move driven primarily by technological advances, and workers in this domain face challenges around managing non-routine...

AI Tool Helps Predict Who will Benefit f…

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who...

AI in Healthcare: How do We Get from Hyp…

The Highland Marketing advisory board met to consider the government's enthusiasm for AI. To date, healthcare has mostly experimented with decision support tools, and their impact on the NHS and...

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

New AI Tool Accelerates Disease Treatmen…

University of Virginia School of Medicine scientists have created a computational tool to accelerate the development of new disease treatments. The tool goes beyond current artificial intelligence (AI) approaches by...